Systems metabolic insights into kaempferol-mediated alleviation of alcoholic fatty liver disease

Systems metabolic insights into kaempferol-mediated alleviation of alcoholic fatty liver disease

IntroductionAlcoholic fatty liver disease (AFLD) is a significant global health concern caused by chronic and excessive alcohol consumption, leading to hepatic steatosis, inflammation, and metabolic disruption. Currently, there are limited effective therapeutic options. Kaempferol, a dietary flavono...

Full description

Saved in:

Bibliographic Details
Main Authors:	Chenmeng Song, Lijia Li, Jia Li, Jengyuan Yao
Format:	Article
Language:	English
Published:	Frontiers Media S.A. 2025-05-01
Series:	Frontiers in Endocrinology
Subjects:	metabolomics alcoholic fatty liver disease (AFLD) kaempferol oxidative stress lipid metabolism
Online Access:	https://www.frontiersin.org/articles/10.3389/fendo.2025.1610613/full
Tags:	Add Tag No Tags, Be the first to tag this record!

Similar Items

Protective Effects of Food-Derived Kaempferol on Pancreatic β-Cells in Type 1 Diabetes Mellitus
by: Chenmeng Song, et al.
Published: (2024-11-01)

Unraveling the molecular mechanisms of Fufangduzhong formula in alleviating high-fat diet-induced non-alcoholic fatty liver disease in mice
by: Yu Mou, et al.
Published: (2025-03-01)

Hepatoprotective Effect of Kaempferol—A Review
by: Przemysław Niziński, et al.
Published: (2025-04-01)

Traditional Mongolian Medicine Qiqirigan-8 alleviates non-alcoholic fatty liver disease via restoring gut microbiota and metabolism
by: Dandan Yang, et al.
Published: (2025-02-01)

Current concepts of the pathogenesis of non-alcoholic fatty liver disease
by: Evgenia Pavlovna Kosobyan, et al.
Published: (2010-03-01)

Extraction of kaempferol from Wattakaka volubilis and evaluation of its protective effects against aluminium-induced liver toxicity
by: Usharani Saminathan, et al.
Published: (2025-08-01)

Diagnostic and pathogenetic significance of apolipoprotein disorders in patients with alcoholic fatty liver
by: Mladenović Bojan, et al.
Published: (2017-01-01)

Evaluation of comorbidity in patients with alcoholic cirrhosis of the liver associated with non-alcoholic fatty liver disease
by: N. R. Matkovska, et al.
Published: (2020-04-01)

Changes in indicators of fibrosis in patients with alcoholic liver cirrhosis associated with non-alcoholic fatty liver disease depending on the stage of cirrhosis
by: N. R. Matkovska, et al.
Published: (2020-06-01)

Study of the effect of human placenta hydrolysate in a new model of metabolic-associated fatty liver disease with iron overload
by: T. E. Bogacheva, et al.
Published: (2025-02-01)

The Interplay of Iron and Lipid Homeostasis in Non-Alcoholic Fatty Liver Disease
by: Clinton J. Kidman, et al.
Published: (2025-03-01)

Metabolic and Genetic Determinants of Lipid Metabolism Disruption in Non-Alcoholic Fatty Liver Disease
by: O. Yu. Kytikova, et al.
Published: (2020-05-01)

Draft Clinical Guidelines for the Diagnosis and Treatment of Metabolically Associated Fatty Liver Disease in Children (Non-Alcoholic Fatty Liver Disease)
by: Alexander A. Baranov, et al.
Published: (2025-05-01)

Features of the State of Internal Organs and the Structure of Comorbidity in Deceased Persons With Alcoholic Liver Cirrhosis, Non-alcoholic Fatty Liver Disease at the Cirrhosis Stage and Alcoholic Liver Cirrhosis Associated With Insulin Resistance and Obesity
by: N. Matkovska
Published: (2020-06-01)

The prevalence of metabolic syndrome in patients with non-alcoholic fatty liver disease in Erbil city
by: Maryam Abdulwahid, et al.
Published: (2024-12-01)

Curcumin and non-alcoholic fatty liver disease
by: Nasrin Sharifi, et al.
Published: (2024-06-01)

Superoxide Scavenging by Capers and Kaempferol, Measured by Hydrodynamic Voltammetry, Shows Kaempferol Synergistic Action with Vitamin C; Density Functional Theory (DFT) Results Support Experimental Kaempferol Catalytic Behavior Similar to Superoxide Dismutases (SODs)
by: Miriam Rossi, et al.
Published: (2025-05-01)

Chronic alcohol intake disrupts cytochrome P450 enzyme activity in alcoholic fatty liver disease: insights into metabolic alterations and therapeutic targets
by: Qian Zhu, et al.
Published: (2025-05-01)

Reactive Oxygen Species as Key Molecules in the Pathogenesis of Alcoholic Fatty Liver Disease and Nonalcoholic Fatty Liver Disease: Future Perspectives
by: Zhiqing Zhang, et al.
Published: (2025-06-01)

Metabolic effects of ursodeoxycholic acid in patients with non-alcoholic fatty liver disease
by: V. A. Akhmedov
Published: (2024-04-01)

Diagnostic accuracy of FibroScan-AST (FAST) score, non-alcoholic fatty liver fibrosis score (NFS), FibroScan, and liver fibrosis index (FIB-4) for identifying fibrotic non-alcoholic steatohepatitis in patients with chronic hepatitis B with metabolic dysfunction-associated fatty liver disease
by: Youwen Tan, et al.
Published: (2024-12-01)

Food fibers in metabolic syndrome and non-alcoholic fatty liver disease
by: E. V. Onuchina
Published: (2021-06-01)

Sex-specific effect of dietary fatty acids on non-alcoholic fatty liver disease
by: Jianhua Chen, et al.
Published: (2025-07-01)

Practical Aspects of Clinical Manifestations, Pathogenesis and Therapy of Alcoholic Liver Disease and Non-alcoholic Fatty Liver Disease: Expert Opinion
by: V. V. Tsukanov, et al.
Published: (2023-11-01)

Molecular Docking Kaempferol sebagai Antiinflamasi pada Aterosklerosis secara In Silico
by: Gede Ngurah Hadi Candra, et al.
Published: (2021-03-01)

Lipid profile and non-alcoholic fatty liver disease detected by ultrasonography: is systemic inflammation a necessary mediator?
by: Wenzhen Li, et al.
Published: (2025-12-01)

Improvement of non-alcoholic fatty liver disease treatment
by: P. I. Seliverstov, et al.
Published: (2014-10-01)

Lipid metabolism indicators provide tools for the diagnosis of non-alcoholic fatty liver disease: results of a nationwide survey
by: Yongxin Wang, et al.
Published: (2025-01-01)

Evolving ideas on non-alcoholic fatty liver disease: from risk to catastrophe
by: Yu. M. Stepanov, et al.
Published: (2020-04-01)

Pharmacokinetic evaluation of the interaction between oral kaempferol and ethanol in rats
by: Zhou Zhaoxiang, et al.
Published: (2016-12-01)

Kaempferol restores the susceptibility of ESBLs Escherichia coli to Ceftiofur
by: Peng-Cheng Li, et al.
Published: (2024-12-01)

Yogurt-derived Lactobacillus plantarum Q16 alleviated high-fat diet-induced non-alcoholic fatty liver disease in mice
by: Chao Tang, et al.
Published: (2022-09-01)

Inter-organ metabolic interaction networks in non-alcoholic fatty liver disease
by: Yu-Hong Fan, et al.
Published: (2025-01-01)

Clinical Significance of Serum Bile Acid Profiles in Fatty Liver
by: Sun HY, et al.
Published: (2024-12-01)

Liver Cirrhosis as the Outcome of Non-Alcoholic Fatty Liver Disease Associated with PNPLA3 Gene RS738409 Polymorphism
by: I. G. Nikitin, et al.
Published: (2020-03-01)

Bacteroides uniformis-generated hexadecanedioic acid ameliorates metabolic-associated fatty liver disease
by: Da-Ya Zhang, et al.
Published: (2025-12-01)

Exploring the mechanism of galangin in alleviating alcoholic fatty liver disease based on the Gene Expression Omnibus database and network pharmacology
by: Yanan Zhao, et al.
Published: (2025-03-01)

Non-Alcoholic Fatty Liver Disease and the Risk of Liver Fibrosis in Chronic Hepatitis B Patients
by: Andri Sanityoso Sulaiman, et al.
Published: (2023-09-01)

Tocotrienol-rich fraction in medium-chain triglyceride carrier upregulates purine metabolism in non-alcoholic fatty liver disease (NAFLD) animal model
by: Mohd Danial Mohd Efendy Goon, et al.
Published: (2025-04-01)

Non-alcoholic fatty liver disease and cardiovascular pathology: pathogenetic parallels
by: G. Yu. Knorring, et al.
Published: (2024-08-01)